XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Series A
Redeemable, Convertible Preferred Stock
Series B
Redeemable, Convertible Preferred Stock
Series C
Redeemable, Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 1,077,303 $ 1,800,347 $ 1,000,465 $ 315 $ (4,206,488) $ (4,206,173)
Balance (in Shares) at Dec. 31, 2020 10,600 5,187 636 3,147,200      
Accretion of redeemable, convertible preferred stock to redemption value $ 44,347 $ 20,396 $ 11,977 (76,720) (76,720)
Stock-based compensation benefit 164 164
Fair value of warrants issued for service 180,339 180,339
Net loss (194,188) (194,188)
Balance at Mar. 31, 2021 $ 1,121,650 $ 1,820,743 $ 1,012,442 $ 315 103,783 (4,400,676) (4,296,578)
Balance (in Shares) at Mar. 31, 2021 10,600 5,187 636 3,147,200      
Balance at Dec. 31, 2021       $ 2,011 28,074,484 (7,694,786) 20,381,709
Balance (in Shares) at Dec. 31, 2021       20,112,244      
Impact of adoption of ASC 842       (5,368) (5,368)
Stock-based compensation expense         126,086 126,086
Exercise of common stock Series B Warrants       $ 4 (4)
Exercise of common stock Series B Warrants (in Shares)       39,000      
Net loss         (2,013,403) (2,013,403)
Balance at Mar. 31, 2022       $ 2,015 $ 28,200,566 $ (9,713,557) $ 18,489,024
Balance (in Shares) at Mar. 31, 2022       20,151,244